Long-Term Safety and Efficacy of KL1333 in Adults with Primary Mitochondrial Disease
- Substances:Napazimone
Italy- Participants:18–64 years · 65+ years
- Substances:Napazimone
- Sponsor:Pharming Technologies B.V.
Rare diseases
Investigational molecules
Locations
Back to Italy207 clinical trials in Messina, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)
ItalyStudy on Eltrombopag for Treating Low and Intermediate Risk Myelodysplastic Syndromes in Patients with Thrombocytopenia
ItalyStudy of Riluzole for Patients with Spinocerebellar Ataxia Type 7
ItalyStudy Comparing FOLFIRI with Cetuximab or Bevacizumab for First-Line Treatment in Patients with Metastatic Colorectal Cancer and Specific Genetic Profiles
ItalyStudy on the Safety and Effectiveness of EIK1001 and Pembrolizumab for Patients with Advanced Melanoma
ItalyA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
ItalyPhase 3 Study of Oral Orforglipron vs Weekly Dulaglutide in Children and Adolescents (10‑<18 years) with Type 2 Diabetes
ItalyEfficacy and safety of ontunisertib in patients with fibrostenosing Crohn’s disease: a phase 2b randomized, double‑blind, placebo‑controlled dose‑ranging trial
ItalyStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
ItalyNHS7108 for Exocrine Pancreatic Insufficiency in Adult Patients
ItalyTreatment Study of Arsenic Trioxide, Tretinoin, and Gemtuzumab Ozogamicin for Children and Adolescents with Acute Promyelocytic Leukemia
ItalyA study to evaluate the effectiveness of MC0518 (mesenchymal stromal cells) in adults with acute graft-versus-host disease that has not responded to steroids and ruxolitinib
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials focusing on hematologic malignancies and solid tumors, including studies on chronic myeloid leukemia, multiple myeloma, and lung cancer treatments.
Research emphasizes targeted therapies and immunotherapy combinations for improved patient outcomes.
Clinical studies investigating treatments for Crohn's disease, ulcerative colitis, and pyoderma gangrenosum, focusing on novel therapeutic approaches.
Emphasis on developing targeted biological therapies for chronic inflammatory conditions.
Groundbreaking research on Rett Syndrome, transthyretin amyloidosis, and polycystic kidney disease, exploring innovative treatment options.
Focus on developing targeted treatments for rare genetic conditions and improving patient quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.